U.S. Energy Services Stock News

If you are wondering whether CoreWeave’s share price still offers value after the recent buzz, this article walks through what the current numbers actually say about the stock. CoreWeave last closed at US$89.93, with returns of 17.0% over 7 days, 14.4% over 30 days and 13.4% year to date. This has understandably caught a lot of investors’ attention around both opportunity and risk. Recent coverage has focused on CoreWeave’s role in the AI infrastructure space and its growing visibility among...

Coca-Cola (KO) is back on investors’ radar after recent share price moves, with the stock roughly flat over the past month but showing a positive total return over the past three months and over the past year. See our latest analysis for Coca-Cola. At a share price of $70.50, Coca-Cola’s recent 7 day share price return of 3.77% sits alongside a 1 year total shareholder return of 17.73%, suggesting momentum has been building rather than fading. If Coca-Cola’s steady returns have you thinking...

This article examines what the current share price of Hims & Hers Health may be implying about the company, and whether the stock still offers good value after its recent performance. The stock recently closed at US$32.34, with a 6.8% decline over 7 days, a 13.1% decline over 30 days, a 3.2% decline year to date, and a 24.9% gain over the past year. Over a longer horizon, it has risen by around 4x over three years and 79.3% over five years. These moves have kept Hims & Hers Health firmly on...

Why Taiwan Semiconductor Manufacturing (TSM) Is Back on Investors’ Radar Taiwan Semiconductor Manufacturing (TSM) has drawn fresh attention after a strong run in recent performance metrics, with shares most recently closing at US$331.77 and multi period returns standing out against its own history. See our latest analysis for Taiwan Semiconductor Manufacturing. That recent 13.60% 1 month share price return and 12.11% 3 month share price return suggest momentum has picked up again. The 66.49%...

JPMorgan Chase (JPM) is back in focus after its recent share move, with the stock closing at $324.49 and showing mixed short term performance that contrasts with stronger multi year total returns. See our latest analysis for JPMorgan Chase. Recent trading has cooled slightly, with a 1 day share price return decline of 1.43% and a 7 day share price return decline of 2.86%. However, JPMorgan Chase still carries strong longer term momentum, highlighted by a 1 year total shareholder return of...

Jefferies Financial Group (JEF) has been in focus after reporting fourth quarter 2025 earnings that combined higher revenue with softer net income and earnings per share, along with an affirmed quarterly cash dividend. See our latest analysis for Jefferies Financial Group. Those fourth quarter numbers and the affirmed dividend come after a mixed price pattern, with Jefferies Financial Group’s share price return of 16.56% over 90 days contrasting with a 9.06% decline in one year total...

Sify Technologies (NasdaqCM:SIFY) has just posted its Q3 2026 numbers, with revenue of ₹11,596 million and a net loss, excluding extra items, of ₹329 million, setting the tone for how investors assess its current footing. The company has seen quarterly revenue move from ₹10,491 million in Q3 2025 to ₹11,596 million in Q3 2026, while trailing 12 month revenue stands at ₹42,550.58 million against a trailing 12 month net loss of ₹1,569.96 million, which keeps the spotlight firmly on its margin...

GigaCloud Technology (GCT) recently reported quarterly results that exceeded analyst expectations and is preparing for its CEO’s presentation at the Needham Growth Conference, giving investors fresh information to assess the stock. See our latest analysis for GigaCloud Technology. Those stronger than expected quarterly figures, the Needham conference appearance and the recent acquisition have arrived alongside a 90 day share price return of 52.83% and a one year total shareholder return of...

If you are wondering whether Equifax's current share price lines up with its underlying worth, you are not alone. This article will help you frame that question clearly. Over the last year, the stock has seen a 9.8% decline, while the year-to-date move sits at 3.6% and the 5-year return stands at 29.8%. This gives a mixed picture for anyone thinking about growth potential or changing risk perceptions. Recent attention on credit data providers and financial infrastructure companies has kept...

Kinder Morgan (KMI) is drawing attention after recently placing about US$500 million of expansion projects into service, including the Altamont Green River Pipeline, while pointing to further completions that it says support its 2026 profit outlook. See our latest analysis for Kinder Morgan. Kinder Morgan’s recent project completions and 2026 profit guidance are landing against a softer share price backdrop, with the stock at US$26.92 after a 1-year total shareholder return of 1.46% decline...

Deckers Outdoor (DECK) is back in focus after recent analyst actions highlighted slowing momentum in its core UGG and Hoka brands, raising fresh questions about how the company balances growth, profitability, and shareholder returns. See our latest analysis for Deckers Outdoor. Those concerns have coincided with a softer tape for the stock, with a 1 day share price return of a 1.9% decline and a 7 day share price return of a 5.8% decline. The 1 year total shareholder return of a 50.2% decline...

Why a wave of lawsuits is putting Coupang (CPNG) under the microscope Multiple securities class actions accusing Coupang of failing to fully disclose a major data breach affecting about 33.7 million customer accounts have pushed cybersecurity and disclosure risk to the forefront for current and prospective shareholders. See our latest analysis for Coupang. The data breach headlines sit against a weaker price backdrop, with Coupang’s share price at US$22.17 and a 30 day share price return of a...

In recent days NovaBay Pharmaceuticals has attracted intense trading interest as it pursued asset sales, preferred stock designations, and leadership changes instead of outright liquidation, while working to maintain its NYSE American listing. This combination of corporate restructuring steps and renewed focus on preserving the public listing has turned the company into a speculative focal point for investors reviewing its remaining options. We’ll now examine how this shift toward...

Waste Management (WM) is back on investor radars after a major Wall Street upgrade, a planned 14.5% dividend increase for 2026, a new US$3b buyback plan, and fresh solar projects on former landfills. See our latest analysis for Waste Management. All of this is landing after a relatively quiet period for the share price, with the stock roughly flat in recent weeks. At the same time, a 1 year total shareholder return of 6.9% and a 5 year total shareholder return of 106.1% point to longer term...

NIO Inc. reported in early January that it achieved record deliveries in December 2025, the fourth quarter, and the full year, reaching 48,135 vehicles for the month, 124,807 for the quarter, and 326,028 for 2025, bringing cumulative deliveries to 997,592 by year-end. The breakdown across its three brands, premium NIO, family-focused ONVO, and small high-end FIREFLY, highlights how its multi-brand approach is broadening its customer base and supporting this surge in volumes. Next, we’ll...

American Airlines Group (AAL) is back in focus after Susquehanna shifted its rating to Positive, joining several large banks that have recently taken a more constructive view on the carrier. See our latest analysis for American Airlines Group. The upgrade comes after a strong run in the share price, with a 90 day share price return of 31.26% and a 30 day share price return of 6.95%, even though the 1 year total shareholder return is still 9.09% lower. That pattern suggests momentum in the...

If you are wondering whether Summit Therapeutics at US$19.68 is starting to look expensive or still offers value, you are not alone. The stock has had a strong run, with returns of 12.8% over the last 7 days, 12.0% over the last 30 days, 12.3% year to date, 8.3% over 1 year and about 3x over 3 years. The 5 year return sits at 271.3%. Recent attention on Summit Therapeutics has been driven by ongoing interest in its pipeline and partnerships within the pharmaceuticals and biotech space. This...

Why Goldman Sachs Group (GS) Is On Investors’ Radar Today Goldman Sachs Group (GS) is drawing attention after recent share price moves, with the stock last closing at $949.55. That level, together with its recent returns, is prompting closer scrutiny from investors. See our latest analysis for Goldman Sachs Group. The recent move to a US$949.55 share price comes after a 6.94% 1 month share price return and a 23.20% 3 month share price return, while the 1 year total shareholder return of...

International Business Machines (IBM) is back in focus after a recent daily move of 2.6%, with the stock closing at $312.18. That shift prompts a closer look at how the shares have been behaving lately. See our latest analysis for International Business Machines. That latest 2.6% daily share price move sits within a broader pattern, with a 7 day share price return of 5.83% and a 90 day share price return of 13.05%. The 1 year total shareholder return of 47.31% and 5 year total shareholder...

T. Rowe Price Group (TROW) is in focus after recent share price moves, with the stock last closing at $106.84. Investors are weighing this price against its fundamentals and its value score of 5. See our latest analysis for T. Rowe Price Group. Recent trading has been relatively steady, with a 1-month share price return of 1.85% and a year to date share price return of 2.11%. The 1-year total shareholder return of 1.70% contrasts with a weaker 5-year total shareholder return of a 14.95%...

If you are wondering whether Raymond James Financial’s recent share price still leaves room for value, this article walks through what the numbers actually say about the stock. The shares last closed at US$170.89, with returns of 2.1% over the past week, 4.3% over the last 30 days, 4.5% year to date, 12.3% over one year, 54.6% over three years and 167.2% over five years. Recent coverage of Raymond James Financial has focused on its role as a diversified financial services firm on the NYSE...

Riot Platforms (RIOT) is drawing attention after accelerating its shift toward AI focused data centers, funded in part by December sales of 1,818 Bitcoin that generated about US$161.6 million in net proceeds. See our latest analysis for Riot Platforms. The recent 7.38% 1 day and 11.22% 7 day share price returns, with the stock now at US$16.45, suggest interest is building again after a 25.87% 90 day share price decline. At the same time, the 39.76% 1 year total shareholder return and 173.26%...

Nebius Group recently announced plans to deploy NVIDIA’s Rubin platform across its Nebius AI Cloud and Nebius Token Factory in US and European data centers from the second half of 2026, expanding support for complex agentic and mixture-of-experts AI workloads alongside existing Blackwell- and Grace-based capacity. This move, combined with Nebius’ multibillion-dollar contracts with Microsoft and Meta and fully booked data center capacity, underlines how the company is tying next-generation...

Why the Tura launch matters for Teledyne Technologies stock Teledyne Technologies (TDY) recently drew attention after Teledyne FLIR OEM introduced Tura, an Automotive Safety Integrity Level B thermal longwave infrared camera aimed at night vision, ADAS, and autonomous vehicle applications. The camera is designed for all weather conditions and supports U.S. safety regulations such as NHTSA's FMVSS No. 127, which may influence how investors view Teledyne's role in automotive safety...